111.
[1]. Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;2(8):998-985.
[2]. Scheepstra M, et al. Bivalent Ligands for Protein Degradation in Drug Discovery. Comput Struct Biotechnol J. 2019;1:10-1. Published 2019 Jan 25.
H02-H15-H19-H5
P21-P24-P20-P21-P280-P02+P52-P04+P40-P05+P51+P8-P0-P2+P4-P40+P2-P405-P501
GHS0